MetaCap

Replimune Group Statistics

NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

19.07-0.16 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Replimune Group by the numbers

Replimune Group has a market capitalization of $1.81 billion based on 94.80M shares outstanding. With trailing EPS of $-2.79, Replimune Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.3% above its 50-day average and 84.9% above its 200-day average.

Average daily trading volume is 2.48M shares, or about $47.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

REPL valuation vs. peer median

REPL compared with the median of 8 peer companies
MetricREPLPeer medianDifference
Market cap$1.81B$1.72B+5%
Avg. volume2.48M1.59M+56%

Peer median across 8 companies: COAG, BCRX, LYCA, MAZE, VIR, RXRX, BEAM, ALVO.

Valuation

Price and trading

Previous close
19.23
Open
18.80
Day range
18.70 – 19.50
52-week range
1.50 – 23.54
52-week change
+107.28%
Beta
—
Volume
1.96M

Dividends and events

Annual dividend
None
Next earnings date
Oct 28, 2026

Additional statistics

Market Cap
1.81B
Forward Pe
-28.43
Eps
-2.79
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
23.54
Week52 Low
1.50
Avg Volume
2.48M
Shares Outstanding
94.80M
Ma50
15.34
Ma200
10.31
Earnings Date
Oct 28, 2026
Pct From52w High
-18.99%
Pct From52w Low
1171.33%

Related